How Does Private Investment in Public Equity Work?

The purchase price in a PIPE is determined through negotiation between the investor and the company, rather than through open market trading. Companies typically offer a discount ranging from five to twenty percent below the trading price, depending on market conditions, the investor's profile, and the size of the investment. The discount reflects the investor's assumption of illiquidity risk during the lock-up period. Larger institutional investors with strong reputations may negotiate smaller discounts, while smaller or less established investors often accept steeper discounts in exchange for access to the opportunity.

Lock-up agreements are contractual arrangements that prevent the investor from selling shares for a defined period, typically ranging from six months to two years. These restrictions exist to protect the public company from sudden dilution and market pressure caused by large share sales. The lock-up period is a critical consideration because it directly affects the investor's liquidity and ability to respond to market changes or portfolio rebalancing needs during that window.

Most PIPE investors receive restricted securities that cannot be resold immediately on the public market. The company typically agrees to register the investor's shares with the Securities and Exchange Commission within a defined period, often 30 to 120 days after closing. Registration allows the investor to resell shares under Rule 144 or pursuant to an effective registration statement, subject to volume and manner-of-sale limitations. Failure to register shares on schedule can trigger penalties, including liquidated damages or anti-dilution adjustments, making registration timing a material contractual obligation for the issuing company.

Beyond federal requirements, investors and companies must comply with state securities laws in jurisdictions where the investor is located or where the company conducts material business. New York courts have addressed PIPE registration disputes and have generally required companies to meet contractual registration obligations or face breach of contract claims. Delays in filing or defects in the registration statement may create grounds for investor remedies if the company's failure materially impairs resale rights.

The primary risk in a PIPE is that the investor's capital becomes illiquid for months or years. If the company's stock price declines during the lock-up period, the investor cannot sell to minimize losses without triggering contractual penalties or seeking a waiver. Market volatility, management changes, or deteriorating business fundamentals can erode the value of the investment while the investor remains contractually bound. Assessing the company's competitive position, debt levels, and near-term catalysts helps frame realistic expectations for the holding period.

PIPE agreements often include anti-dilution provisions that protect the investor if the company issues additional shares at lower prices. However, these protections vary widely and may not cover all forms of dilution. Investors should carefully review whether anti-dilution adjustments apply only to future equity issuances or whether they extend to other capital-raising mechanisms, such as convertible debt or warrants. Understanding the breadth of anti-dilution protection helps clarify the investor's downside protection if the company's valuation deteriorates.

Timing of share registration matters significantly because market conditions at the moment of resale availability can differ dramatically from conditions at the time of purchase. If the company delays registration or if registration occurs during a market downturn, the investor's ability to achieve favorable pricing is constrained. Companies operating in healthcare private equity contexts may face additional regulatory scrutiny that delays registration. Investors in healthcare-focused PIPE deals should factor in longer timelines for SEC review and potential state regulatory approvals.